Karthik Radhakrishnan
CIK 1573327 · Chief Financial Officer · last filed 2024-10-30
Karthik Radhakrishnan is a Chief Financial Officer who has filed 8 SEC Form 4 insider transactions across 2 companies since 2013. The most recent filing shows the insider bought $25.2K of MNPR on Oct 30, 2024. Across all open-market trades the lifetime net is +$113.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $92.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$92.6K
2
8
$113.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MNPR | Chief Financial Officer | 1,550 | $59.77 | $92.6K | $25.2K | 2 | 2024-10-30 |
| Acer Therapeutics Inc. (OPXAW) Delisted | Chief Financial Officer | 124,659 | — | — | $88.6K | 6 | 2015-04-09 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-10-30 | MNPR | Buy (P) | +1,550 | $25.2K | EDGAR |
| 2024-07-03 | MNPR | Grant (A) | — | $0 | EDGAR |
| 2015-04-09 | Acer Therapeutics Inc. (OPXAW) Delisted | Exer (M) | +50,000 | $0 | EDGAR |
| 2015-03-04 | Acer Therapeutics Inc. (OPXAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-03-04 | Acer Therapeutics Inc. (OPXAW) Delisted | Grant (A) | +16,659 | $0 | EDGAR |
| 2013-12-18 | Acer Therapeutics Inc. (OPXAW) Delisted | Buy (P) | +8,000 | $13.6K | EDGAR |
| 2013-08-09 | Acer Therapeutics Inc. (OPXAW) Delisted | Buy (P) | +50,000 | $75.0K | EDGAR |
| 2013-04-01 | Acer Therapeutics Inc. (OPXAW) Delisted | Grant (A) | — | $0 | EDGAR |